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Introduction
Cell migration requires the coordinated activity of several modu­
lar processes, including formation and turnover of focal adhesion 
(FA) sites, actin dynamics, and polarized distribution of adaptor 
and signaling proteins. Growing evidence suggests the impor­
tance of endosomes for the local regulation of these processes 
(Sadowski et al., 2009; Scita and Di Fiore, 2010; Schiefermeier 
et al., 2011). Among the proteins suggested to use different subsets 
of endosomes as mobile platforms are well­known regulators of 
cell motility such as Rac (Palamidessi et al., 2008), Cdc42 (Osmani 
et al., 2010; Huang et al., 2011), Src (Tu et al., 2010), Endo 180 
(Sturge et al., 2006), and PTPD1 (Carlucci et al., 2010).
The p14–MP1 (LAMTOR2/3, MAPK/ERK kinase 1 part­
ner MP1, and its endosomal adaptor protein p14) protein com­
plex was established as a late endosomal MAPK scaffold complex 
(Wunderlich et al., 2001; Kurzbauer et al., 2004). Moreover, p14–
MP1 was shown to regulate mTOR signaling, organization of the 
late endosomal compartment, cell migration, cell spreading, and 
proliferation (Teis et al., 2002, 2006; Pullikuth et al., 2005; Park 
et al., 2009; Sancak et al., 2010). Interestingly, previous findings 
demonstrated that FAs in fibroblasts are specifically targeted by 
microtubules (MTs). Thereby, MTs deliver a so­far unidentified 
relaxing signal to modify FA dynamics in a kinesin­1–dependent 
manner (Kaverina et al., 1999; Krylyshkina et al., 2002). Recently, 
binding of late endosomal membranes to kinesin­1 was shown to 
require the Arl8b­GTP protein (Bagshaw et al., 2006; Hofmann 
and Munro, 2006; Rosa­Ferreira and Munro, 2011), but how 
Arl8b impacts on cell migration was not investigated.
Additionally, IQGAP1 was suggested to regulate cell mi­
gration in several ways. It binds directly to multiple proteins, 
including known cytoskeleton regulators (actin, myosin light 
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To understand how the late endosomal p14–MP1 complex 
contributes to cell migration we analyzed FAs by immunostain­
ing for Paxillin (Fig. 1 C). In control p14f/ MEFs, different 
populations of substrate adhesions could be distinguished, 
including small punctuated focal complexes at the leading edge 
(Fig. 1 C, red arrowheads), mature FAs of different sizes in the 
cell body, and trailing FAs at the cell rear. In contrast, in p14/ 
MEFs, small FCs were difficult to detect, whereas elongated 
FAs were prominently enriched at the cell periphery (Fig. 1 C, 
red arrows).
On average, FA length was twofold increased in p14/ 
MEFs versus p14f/ MEFs (Fig. 1 D and Table S1). Frequency 
distribution analysis of FA subpopulations revealed that control 
p14f/ MEFs contained two major groups of FAs with sizes 
between 0.5 and 1.0 µm (41.9% of all adhesions) or with sizes 
between 1.0 and 1.5 µm (30.5%). In contrast, the majority of FAs 
was longer than 1.5 µm in p14/ MEFs (Fig. 1 D, length distri­
bution graph; and Table S2). Importantly, FA length and distri­
bution could be rescued by retroviral re­expression of p14­GFP. 
However, FA defects were not rescued by the expression of 
myc6­MP1 alone, which remains cytoplasmic due to the loss 
of its late endosomal binding partner p14. Expression of a 
CAAX­tagged p14, which redirects the p14–MP1 complex to 
the plasma membrane (Wunderlich et al., 2001), also failed to 
rescue FA length and distribution. This indicates that the late 
endosomal localization of the p14–MP1 complex was required 
for FA regulation (Fig. 1, C and D). In line with this hypothesis, 
we have also observed significant FA elongation in HeLa cells 
where MP1 was down­regulated (Fig. S1, C and D).
To test if loss of p14 affects activation of integrins, we 
performed FACS analyses revealing that 1, 3, 5, and V in­
tegrins were expressed at similar levels in p14f/ MEFs and 
p14/ MEFs and that 2, 4, 1, 2, and 6 integrins were not 
detectable (Fig. S2). Moreover, MnCl2 treatment activated 1 
integrins to a similar extent in p14f/ and p14/ MEFs (Fig. 1 E), 
indicating that the p14–MP1 complex neither regulated cell sur­
face expression nor activation of integrins.
Although immunostaining for Paxillin reveals the major­
ity of adhesion sites, another focal adhesion protein, Zyxin, was 
shown to incorporate into adhesions at a later maturation stage 
and to colocalize with Paxillin only in the larger, definitive 
FAs (Zaidel­Bar et al., 2003). Double immunolabeling for 
Paxillin and Zyxin revealed that FAs in p14/ MEFs contained 
Zyxin (Fig. 2 A).
To directly address if FA dynamics were altered in p14/ 
MEFs, we performed FRAP of mCherry­Paxillin. Previous 
FRAP studies revealed that FAs differ in their dynamic protein 
exchange rate and density of their components, which in turn af­
fects FA remodeling (Ballestrem et al., 2001; Wolfenson et al., 
2009). We performed the FRAP experiments with MEFs that 
were transiently expressing mCherry­Paxillin (Laukaitis et al., 
2001). FAs that were at least 1 µm in length were photobleached 
and FRAP was measured (Fig. 2 B). Whereas the kinetics of 
mCherry­Paxillin recovery did not differ in p14f/, p14/, and 
p14/;p14­GFP MEFs (Thalf = 14.03 ± 1.3, 14.03 ± 1.5, and 
12.05 ± 2.2 s, respectively), the extent of recovery was strongly 
reduced in p14/ MEFs, reaching only 60% of control MEFs. 
chain­2, Rac1, Cdc42, adenomatous polyposis coli [APC], and 
CLIP­170 [Brown and Sacks, 2006]). IQGAP1 localizes MEK 
and ERK to dynamic MTs (Roy et al., 2004, 2005) and also 
binds components of the MAPK pathway such as B­Raf, MEK1, 
MEK2, ERK1, and ERK2 (Roy et al., 2004, 2005). Transfection 
of dominant­negative mutants or down­regulation of IQGAP1 
by RNAi reduces cell motility in some cell lines (Hart et al., 
1996; Mataraza et al., 2003). Recently, IQGAP1 was identified 
in FAs (Kuo et al., 2011; Schiller et al., 2011) and in focal com­
plexes (FCs) of keratinocytes, where it binds to the integrin­
linked kinase ILK (Wickström et al., 2010). Whether IQGAP1 
interacts with FA proteins or is directly involved in regulation of 
FA dynamics is unknown.
Here, we report that the p14–MP1 (LAMTOR2/3) com­
plex regulates FA dynamics and cell migration from late endo­
somes. Small but distinct subpopulations of the Rab7­positive 
late endosomes, which carry the p14–MP1 scaffold complex, 
move along MTs in an Arl8b­dependent manner to the cell pe­
riphery where they specifically target FAs. Using genetically 
modified fibroblasts from p14­deficient mice, we demonstrate 
that the late endosomal p14–MP1 complex is essential for FA 
dynamics. MT plus end–directed transport of the p14–MP1 com­
plex regulates localization and association of IQGAP1 to mature 
FAs and thereby controls FA dynamics. In summary, our results 
suggest a new function for the p14–MP1 complex in local 
regulation of FAs and thus demonstrate a crucial role for spe­
cific subsets of late endosomes during cell migration.
Results
Impaired cell migration and FA remodeling 
in p14/ knockout MEFs
Previously, down­regulation of p14–MP1 by RNAi was shown 
to inhibit migration of prostate cancer cells (Park et al., 2009). 
To test specifically if the knockout of the p14–MP1 complex 
contributes to cell migration, we performed wound­healing 
assays. Confluent cell layers of immortalized control p14f/ and 
p14/ knockout mouse embryonic fibroblasts (MEFs; Teis et al., 
2006) were scratched and wound closure was recorded by 
time­lapse microscopy (Fig. 1 A and Video 1). In the p14/ 
knockout MEFs, MP1 no longer localizes to late endosomes and 
was degraded (Teis et al., 2006). The p14f/ control MEFs ad­
opted a typical fibroblast migration behavior with a single lead­
ing edge facing the wound and closed the scratched area in 
approximately 10 h. In contrast, the p14/ MEFs failed to form 
a clear leading edge, but instead developed multiple elongated 
protrusions that did not result in active migration into the 
scratched area (Fig. S1 A). The migration speed of control cells 
was 15 ± 3.5 µm/h (mean ± SD), as compared with 5 ± 0.98 µm/h 
for p14/ MEFs (Fig. 1 B). The migration defect could be res­
cued by retroviral re­expression of a fully functional p14­GFP 
(11.61 ± 3.17 µm/h; Fig. 1, A and B; and Video 1; Stasyk et al., 
2010). The migration speed of p14/ MEFs in a random single­
cell migration assay was also two times slower compared with 
their controls (p14f/ MEFs, 49.13 ± 11.36 µm/h vs. p14/ MEFs, 
23.36 ± 9.93 µm/h; Fig. S1 B).
monitored FA dynamics over a period of 60–80 min (Videos 2 
and 3; and Fig. 2, C and D). FA turnover was visualized by 
overlaying single frame shots of three different time points, sum­
marizing a 20­min time span. The merged FA snapshots show 
decreased FA dynamics (white areas) in the p14/ MEFs com­
pared with the control cells (Fig. 2 C). Then, we manually 
tracked single FAs over time to analyze their stability in control 
and p14/ MEFs (Fig. 2 D). We analyzed the longevity of existing 
The reduced overall recovery of mCherry­Paxillin revealed that 
Paxillin could not be efficiently exchanged, suggesting that 
FAs in the p14/ MEFs contained a large proportion of immobile 
Paxillin molecules. Reconstitution of the late endosomal p14–
MP1­signaling complex in p14/;p14­GFP MEFs rescued the 
recovery of mCherry­Paxillin (up to 90%; Fig. 2 B, graph).
Next, we performed total internal reflection fluorescence 
(TIRF) microscopy of mRuby­Paxillin–transfected MEFs and 
Figure 1. Loss of p14–MP1 endosomal signal-
ing impairs cell migration and FA. (A) Migra-
tion of MEFs in wound-healing assay. Red lines 
depict edges of the wound. See also Video 1. 
(B) Calculation of migration speed of MEFs in 
wound-healing assay (µm/h, mean of cell mi-
gration speeds ± SD; **, P < 0.001, Student’s 
t test). (C) IF: anti-Paxillin antibody. Note for-
mation of elongated peripheral FAs in p14/ 
MEFs (red arrows) compared with FAs and FCs 
at the leading edge of the control p14f/ MEFs 
(red arrowheads). Expression of myc6-MP1 or 
Xpress-p14-CAAX does not restore FA pattern 
in p14/ MEFs (presence of myc6-MP1 is 
confirmed by anti-myc antibody showing cyto-
plasmic distribution of MP1, presence of p14-
CAAX is confirmed by anti-Xpress antibody). 
Reduction of FA size can be achieved by ex-
pression of p14-GFP (blue arrowheads, pres-
ence and localization of p14-GFP is confirmed 
by GFP image). Bar, 10 µm. (D) Quantification 
of average FA length and detailed analyzes of 
FA populations (“Length distribution”) in MEFs. 
Left graph: mean in percent ± SEM compared 
with control p14f/ MEFs (mean of FA length 
in control p14f/ MEFs was taken as 100%). 
Right graph: FAs are clustered in four speci-
fied length groups (x-axis) and are presented 
in percentage of all adhesions (y-axis) in each 
type of MEFs. See also Table S1. (E) FACS 
analysis of activated 1 integrins (identified 
with 9EG7 antibody) reveals no difference 
in expression in p14f/ MEFs (black line) and 
p14/ MEFs (blue line; dotted lines indicate 
negative controls). The data shown are from a 
single representative experiment out of three 
independent experiments. For complete integ-
rin profile, see Fig. S2.
Figure 2. Analysis of FA turnover. (A) IF of p14f/ and p14/ MEFs with anti-Paxillin and anti-Zyxin antibodies. White arrows indicate leading edge 
formation areas in the control cells where no Zyxin-positive FAs are detected (magnification). In the p14 knockout MEFs the overall elongated FAs are also 
positive for Zyxin (magnification). (B) FRAP analysis of FAs in indicated MEFs. Image shows representative example of FAs (white arrows) before bleaching 
and during recovery time in p14f/ MEFs. Graph shows curves of fluorescence recovery (mean of 10 cells per group, number of measured FAs = 60) after 
bleaching of indicated MEFs. (C) TIRF microscopy of MEFs expressing mRuby-Paxillin. See also Videos 2 and 3. Shown are mature FAs of magnified areas 
with FAs (Fig. 3 A). By tracking the localization of the p14–
MP1 endosomes using time­lapse epifluorescence microscopy 
(Fig. 3 B and Video 4), we observed that a small population of 
late endosomes underwent directional anterograde transport and 
targeted FAs. Targeting events included targeting of a single FA, 
movement of late endosomes from one FA to another (Video 4), 
and targeting of a single FA repetitively (Fig. 3 B, white arrows). 
TIRF time­lapse microscopy and single­particle tracking re­
vealed that the repetitive targeting of FAs by p14–MP1 endo­
somes occurred within less than approximately 100 nm (Fig. 3 C 
and Video 5). A GFP channel Z­projection of all frames recorded 
in Video 5, merged with mCherry­Paxillin FAs in the red channel, 
(Fig. 2 D, left graph) and newly formed (Fig. 2 D, right graph) 
FAs. Collectively, our findings show that FA turnover is de­
creased in p14/ MEFs.
MP1-carrying late endosomes target 
dynamic FAs
The potential contribution of local late endosomal signaling for 
the regulation of FAs was investigated in cells expressing GFP­
MP1 (localizes to late endosomes; Wunderlich et al., 2001) and 
mCherry­Paxillin, which is present in FAs. Co­expression of 
GFP­MP1 and mCherry­Paxillin in NIH3T3 and HeLa cells re­
vealed a partial colocalization of MP1­carrying late endosomes 
of control and p14 knockout MEFs at three different timeframes (1 frame = 10 min). Merging of the three color-coded frames indicates the development of 
single FAs over time. Note: white FAs are stable over the shown time period (20 min). (D) Quantification of FA turnover. The left graph displays the existence 
of single FAs (n = 168) as dots over a time period of 60 min. All existing FAs were included. The right graph shows dynamic FA events. New growing FAs 
were analyzed during a time period of 80 min (P < 0.001).
Figure 3. p14–MP1-carrying late endosomes 
target FAs. (A) IF of p14–MP1-carrying endo-
somes colocalizing with FAs in cells coexpress-
ing GFP-MP1 (green) and mCherry-Paxillin 
(red; see white arrowheads). (B) NIH3T3 cell 
coexpressing GFP-MP1 (green) and mCherry-
Paxillin (red). White arrows: FAs repetitively 
targeted by p14–MP1-carrying endosomes. 
See Video 4. (C) TIRF microscopy. Overlay 
of MP1-GFP Z-projection (green) and FAs 
(mCherry-Paxillin is shown in red). White ar-
rowheads on selected time-lapse images point 
to individual MP1 endosomes (green) that tar-
get FAs (red). See Video 5. (D) Colocalization 
of MP1 with Rab7 and Transferrin. Top: images 
from time-lapse series of HeLa cell coexpress-
ing GFP-MP1 (green) and mCherry-Rab7 (red). 
GFP-MP1 colocalizes with mCherry-Rab7 in 
cell center and cell periphery. Deconvolved 
image from the time-lapse shows colocaliza-
tion of MP1 (green) and Rab7 (red) on ring-
like structures of endosomes. Bottom: uptake of 
Transferrin (red) in HeLa cell expressing GFP-
MP1 (green). (E) Quantification of the colocal-
ization (mean ± SEM) between Rab7 and MP1 
versus Transferrin and MP1. Insets in A and D 
are taken from white boxes in main panels.
FAs is shown in Fig. 4 C). “Stable” segments (unchanged over 
time) and “dynamic” segments (areas changing between video 
frames) of individual FAs were identified and fluorescence colo­
calization of each segment was separately calculated (Fig. 4 C, 
“Targeting of FA segments” graph). Interestingly, dynamic seg­
ments of FAs were targeted significantly more often when com­
pared with stable ones (77 ± 1.4% vs. 23 ± 0.9%; Fig. 4 C).
demonstrated an accumulation of MP1­GFP in close vicinity of 
FAs (Fig. 3 C).
MP1­GFP only occasionally colocalized (3–8.4%) with 
transferrin­positive early and recycling endosomes in transfer­
rin uptake pulse­chase experiments (Fig. 3, D [bottom] and E). 
In contrast, MP1­GFP–positive late endosomes that targeted 
FAs (examples are shown in Fig. 3 D) colocalized with 94% of 
all mCherry­Rab7–positive structures, consistent with previous 
studies (Teis et al., 2002; Kurzbauer et al., 2004; Fig. 3, D [top] 
and E). These findings demonstrate that FAs were targeted by 
late endosomes that carry the p14–MP1 complex.
p14–MP1-carrying endosomes target 
mature FAs, but not FCs
Next, we asked whether all or only subpopulations of integrin 
adhesion sites get targeted by p14–MP1­containing endosomes. 
Previous experiments after siRNA depletion of MP1 in a pros­
tate cancer line have indicated an involvement of MP1 in cell 
spreading (Pullikuth et al., 2005). However, we did not observe 
FA targeting of de novo–formed nascent FCs and FAs during 
cell spreading (Fig. S3 and Video 6).
FA targeting by p14–MP1 endosomes was further ana­
lyzed over a period of 2 h. The percentage of colocalization of 
fluorescence signals from mCherry­Paxillin (red channel) and 
GFP­MP1 (green channel) was calculated (Fig. 4, A and B; over­
all targeting in each experiment is taken as 100%; for details see 
Materials and methods). The overall frequency of targeting 
events in each frame of time­lapse sequences was 90.5 ± 1% 
(±SEM; n [FA] = 60; Fig. 4 B, “Targeting of FA”graph). Over 
2 h, mature FAs were growing, sliding when cells moved (trans­
location revealed by recording changes of their XY coordinates), 
and some FAs were formed whereas others disappeared. The 
most stable FAs existed longer throughout the video sequence 
and were changing in XY the least. To distinguish between these 
particular subpopulations of FAs, we introduced the following 
parameters: “length of FA tracks” was used to identify sliding 
FAs, and “FA lifetime” to identify stationary FAs. An example 
of a processed video sequence and FA tracking used for cal­
culations is shown in Fig. 4 A. Using these parameters we di­
vided all FAs analyzed into three groups: (1) highly dynamic 
FAs (0–1.6­µm FA track, 0–20­min lifetime, indicated with 
green arrows on the graphs); (2) mature stable FAs (0–4.8 µm 
and 20–120 min, blue arrows); and (3) sliding FAs (4.8–11.3 µm 
and 0–40 min, red arrows).
All populations of FAs were targeted actively by endo­
somes (Fig. 4 B, “Length of FA track” and “FA lifetime” graphs). 
FAs with the longest FA tracks were targeted more often (38.7 ± 
0.9%) compared to those with shorter FA tracks (23.3 ± 0.6%, 
17 ± 0.9%, and 21 ± 1.9%; see Fig. 4 B). FAs existing in cells 
over 20–40 min were more often targeted (55.9 ± 6%) when com­
pared to FAs with shorter lifetimes (0–20 min, 19.1 ± 5.1%) or 
very long lifetimes (40–120 min, 25 ± 2.7%). Sliding FAs were 
targeted most frequently (Fig. 4 B, red arrows).
Next, the colocalization of Paxillin/MP1 fluorescence sig­
nals in different parts of individual FAs was analyzed (Fig. 4 C). 
Each FA area was divided into segments with respect to the change 
of its fluorescence signal over time (schematic segmentation of 
Figure 4. MP1 endosomes target mature FAs, but neither FCs nor newly 
formed FAs. (A) HeLa cells expressing GFP-MP1 (green) and mCherry-Paxillin 
(red) are used for detailed quantification of FA targeting. Top: images 
from the video sequence showing overlay of FAs (red) and endosomal 
(green) masks. Bottom: center of each FA was identified as a round sphere 
(purple) and used for further FA tracking. FA tracks (black arrows) during 
time lapse are illustrated in a line of different colors, indicating temporal 
changes of FA positions (as shown on the color bar below). (B) Quanti-
fication of the FA targeting by p14–MP1-carrying endosomes (mean in 
percentage ± SEM) and of FA targeting (per frame) during the time lapse. 
Green arrows indicate parameter combination of highly dynamic FAs, blue 
arrows of mature stable FAs, and red arrows of sliding FAs. Experiments 
were repeated three times, n = 10 (n = the number of cells used for quan-
tification). (C) Schematic segmentation of FAs dissected with respect to 
the change of its fluorescence signal over time (left image). Right graph 
depictures mean calculation of fluorescence MP1–Paxillin colocalization in 
the FA segments. Experiments were repeated three times, n = 10 (n = the 
number of cells used for quantification).
example of an individual endosome (Fig. 5 A and Video 8) dem­
onstrated that the endosome used a single MT to move to 
FAs, where it was trapped as soon as the MT stopped growing 
and depolymerized. Next, we treated cells with nocodazole to de­
polymerize MTs (Fig. 5 B). Nocodazole treatment completely 
abrogated the movement of p14–MP1 endosomes. A few MP1 
endosomes remained at FAs, whereas the majority accumulated 
in the perinuclear region or displayed dispersed cytoplasmic lo­
calization (Fig. 5 B, white arrows). Thus, anterograde movement 
Arl8b-dependent MT plus end–directed 
transport of late endosomes regulates FAs
Late endosomes are transported along MTs in a retrograde man­
ner (Pastan and Willingham, 1981). To test whether the observed 
anterograde movement of p14–MP1­carrying endosomes toward 
FAs also utilizes MTs, we analyzed by time­lapse microscopy 
cells triply transfected with mCherry­Paxillin, mCherry­Tubulin, 
and GPF­MP1. We found that p14–MP1 endosomes were moving 
along MTs toward FAs (Fig. 5 A and Video 7). A representative 
Figure 5. Arl8b-dependent MT plus end–directed transport of late endosomes regulates FAs. (A) MP1 endosomes are transported along MTs. Time-
lapse images of HeLa cells expressing GFP-MP1 (green), mCherry-Paxillin (red), and mCherry-tubulin (red) show colocalization of MP1 and MTs (white 
arrowheads). Representative individual endosome moves along MTs toward two FAs (bottom panels, white arrowheads). See also Video 7 and 8. 
(B) Nocodazole treatment of a cell transfected as in A results in MT depolymerization and “trapping” of few GFP-MP1 endosomes in FAs (white arrows and 
arrowheads). Time-lapse images of the same cell show that positions of GFP-MP1 endosomes do not change in time due to abolished MP1 transport. 
(C) Arl8b knockdown in MEFs. IF: anti-LAMP1 (green), anti-tubulin (red) antibodies, and Hoechst. LAMP1-positive late endosomes collapse to the perinuclear 
region upon Arl8b knockdown (white arrow). WB: anti-Arl8b antibody, anti-tubulin used as loading control. (D) The p14/;p14-GFP MEFs treated with 
control and Arl8b RNAi. The late p14-GFP endosomes cluster in the Arl8b RNAi-treated cells (red arrow). See also Video 9. (E) The graph on the left 
shows the quantification of average FA length in MEFs. Mean in percent ± SEM compared with control p14f/ MEFs treated with control RNAi (mean of 
FA length in control p14f/ MEFs treated with control RNAi was taken as 100%). See also Table S1. The graph on the right shows the migration speed of 
p14/;p14-GFP MEFs transfected with control (n = 26) and Arl8b siRNA (n = 66) in wound-healing assay (µm/h, mean of cell migration speeds ± SD). 
(F) Colocalization of Paxillin and Rab7 in MEFs. Images from time-lapse series of MEF cells coexpressing GFP-Rab7 (green) and mCherry-Paxillin (red). White 
arrows indicate FAs targeted by GFP-Rab7. See also Video 10.
of MP1­carrying endosomes required intact MTs and can there­
fore be considered as plus end–directed transport.
Arl8b­GTP was shown to associate with the late endo­
somal membranes and to ensure binding of the late endosomes 
to the motor protein kinesin­1 (Bagshaw et al., 2006; Hofmann 
and Munro, 2006; Rosa­Ferreira and Munro, 2011). To confirm 
that FA targeting by p14–MP1 endosomes and its effect on FA 
elongation involves active kinesin­dependent transport, we de­
pleted Arl8b protein by RNAi in MEFs (Fig. 5 C). Depletion of 
Arl8b had no visible effect on MT patterns and led to cluster­
ing of LAMP1­positive late endosomes in the perinuclear area 
(Fig. 5 C, white arrow). We performed time­lapse micros­
copy in p14/ MEF;p14­GFP (Fig. 5 D and Video 9). In cells 
treated with control RNAi, p14­GFP endosomes moved actively 
throughout the cell, whereas down­regulation of Arl8b caused 
clustering of p14­GFP late endosomes in the perinuclear region 
of cells (Fig. 5 D, red arrow; and Video 9).
Next, we performed immunostaining for Paxillin and mea­
sured FA length (Fig. 5 E and Table S1). Interestingly, FA length 
was not further affected in p14/ MEFs upon Arl8b knockdown 
(Fig. 5 E and Table S1). However, in p14f/ MEFs treated with 
Arl8b RNAi, length of FAs was twofold increased as compared 
with p14f/ MEFs treated with control RNAi (Fig. 5 E, left graph; 
and Table S1). Additionally, we analyzed the migration speed of 
Arl8b RNAi–treated cells in a wound­healing assay. In compar­
ison to control siRNA treated cells, knockdown of Arl8b in 
p14/ MEF;p14­GFP decreased the migration speed by 30% 
as compared with the control cells (Fig. 5 E, right graph). These 
results suggest that active transport of late endosomes requires 
Arl8b to regulate FAs.
Interestingly, late endosomes were transported toward 
FAs also in the absence of the p14–MP1 complex, as revealed 
by time­lapse microscopy in p14f/ MEF and p14/ MEF cells 
cotransfected with mCherry­Paxillin and GPF­Rab7 (Fig. 5 F 
and Video 10).
IQGAP1 is a novel interacting protein  
of MP1
To further investigate how the p14–MP1 complex would regu­
late FA dynamics, we performed a two­hybrid screen using 
MP1 as bait in order to identify potential interaction partners. 
Human IQGAP1 (GenBank accession no. NM_003870) was 
identified as an MP1­interacting protein in 24 positive hits. To 
confirm this interaction we first used p14f/ MEF cells stably 
Figure 6. IQGAP1 and MP1 interaction. (A) Reciprocal co-immunoprecipi-
tation of myc6-MP1 and IQGAP1. Cell extracts were prepared from myc6-
MP1–expressing p14f/ MEFs. IP: with anti-myc (lane 2) and anti-IQGAP1 
(lane 3) polyclonal antibodies; IgG control (lane 1). WB: anti-IQGAP1 
(top) and anti-myc (bottom) antibodies, respectively. Black arrow indicates 
myc6-MP1 signal. (B) Immunoprecipitation of endogenous MP1 and p18. 
Cell extracts were prepared from HeLa cells. IP: with anti-IQGAP1 (lane 3) 
polyclonal antibody; cell lysates (lane 1), IgG control (lane 2). WB: 
anti-IQGAP1 (top), anti-p18 (middle), and anti-MP1 (bottom) antibodies, 
respectively. (C) Top: HeLa protein lysates were incubated with GST-MP1 
or GST alone immobilized on glutathione-Sepharose beads. WB: anti-
IQGAP1 antibody. Lysates not subjected to GST pull-down were processed 
in parallel (HeLa lysate). Bottom: HeLa protein lysates were incubated with 
GST-IQGAP1 or GST alone immobilized on glutathione-Sepharose beads. 
WB: anti-MP1 antibody. Lysates not subjected to GST pull-down were pro-
cessed in parallel (HeLa lysate). Black arrow indicates MP1 signal.
IQGAP1 was reduced in the leading edge and accumulated in 
FAs (Fig. 7 C, white and red arrows), where it colocalized with 
Paxillin (Fig. 7 D, white and red arrows). Thus, knockdown of 
Arl8b in control p14f/ MEF cells phenocopied the loss of the 
p14–MP1 complex.
Down-regulation of IQGAP1 rescues FAs 
and cell migration in p14/ knockout MEFs
To further investigate the interaction of IQGAP1 with p14–MP1 
in regulation of FAs, we depleted IQGAP1 protein by RNAi. 
Reduction of IQGAP1 was efficient in p14f/ and p14/ MEFs 
(immunofluorescence [IF] in Fig. 8, Western blotting [WB] 
in Fig. S5 A). In control p14f/ MEFs treated with IQGAP1 
RNAi, FAs were somewhat elongated (22.3%) as compared with 
p14f/ MEFs treated with control RNAi (Fig. 8 B, left graph; 
and Table S1). Interestingly, the IQGAP1 knockdown in p14/ 
MEFs strongly decreased the length of FAs (56.6% decrease, as 
compared with p14/ MEFs treated with control RNAi).
Furthermore, we performed wound­healing assays and 
measured speed of cell migration (Fig. 8 B, right graph; and 
Fig. S5 B). Depletion of IQGAP1 had no significant effect on cell 
migration in control p14f/ MEFs (15 ± 0.16 µm/h, mean ± SEM 
in p14f/ MEFs treated with control RNAi vs. 14.7 ± 0.16 µm/h 
in p14f/ MEFs treated with IQGAP1 RNAi). However, knock­
down of IQGAP1 in p14/ MEFs promoted cell migration and 
efficiently rescued the migration defect observed in p14/ 
MEFs (13.9 ± 0.20 µm/h as compared with 8.6 ± 0.10 µm/h of 
the respective control cells). These results suggest that in the ab­
sence of the p14–MP1 complex, IQGAP1 accumulation at FAs 
correlated with elongation of FAs and impaired cell migration.
Discussion
In the current work, we observed that p14–MP1 (LAMTOR2/3)­
carrying late endosomes are transported from the cell center to­
ward FAs. However, these perinuclear organelles can also undergo 
anterograde kinesin­dependent transport, although the biologi­
cal role of the outward movement has remained so far unclear 
(Hollenbeck and Swanson, 1990; Feiguin et al., 1994; Nakata 
and Hirokawa, 1995).
Here, we demonstrated that the MT plus end–directed 
movement of a small but steadily p14–MP1­carrying, Rab7­
positive, late endosome subpopulation was followed by directed 
targeting of FAs. Importantly, mature FAs (but not FCs) were 
actively targeted by p14–MP1­carrying endosomes, indicating 
that p14–MP1 is not directly involved in the recycling of FA 
components in newly formed adhesions. FAs can grow and 
translocate (slide) by treadmilling where integrins are added on 
the one end of FAs and removed from the other (Geiger and 
Bershadsky, 2001). Most of the targeting events by p14–MP1 
we observed in sliding FAs, proposed to be important for cell 
translocation (Ballestrem et al., 2001; Rid et al., 2005). More­
over, segmentation of individual FAs into dynamic (changing) 
and stable segments revealed that endosomal targeting mainly 
took place in the dynamic areas where adhesion components are 
either added or removed. Thereby, the p14–MP1 complex might 
locally regulate FA remodeling.
expressing myc6­MP1 for immunoprecipitation studies. Immuno­
precipitation of endogenous IQGAP1 resulted in the co­immuno­
precipitation of myc6­MP1 (Fig. 6 A) and endogenous IQGAP1 
was detected in the myc6­MP1 immunoprecipitates (Fig. 6 A). 
We further extended these interaction studies with co­immuno­
precipitation of IQGAP1 and detection of the endogenous MP1 
and p18 (LAMTOR1) proteins, the latter one representing the 
membrane anchor of the p14–MP1 complex (Fig. 6 B). Finally, 
HeLa protein lysates were incubated with GST­MP1, GST­
IQGAP1, or GST alone immobilized on glutathione­Sepharose.
In vitro–purified GST­MP1 interacted with endogenous 
IQGAP1 (Fig. 6 C, top) and in the reciprocal experiment in vitro–
purified GST­IQGAP1 interacted with endogenous MP1 (Fig. 6 C, 
bottom), demonstrating that MP1 and IQGAP1 interact and hence 
confirming the two­hybrid interaction.
Furthermore, we confirmed the IQGAP1­MP1 interaction 
in situ using a Duolink proximity ligation assay (PLA). Because 
the available MP1 antibodies failed to detect MP1 in conven­
tional immunofluorescence experiments, we used p14f/ MEFs 
stably expressing myc6­MP1, which specifically localizes to 
late endosomes (Fig. S4 A; Teis et al., 2006). In the PLA assay 
we used different sets of two primary antibodies to detect myc6­
MP1 (rabbit) and IQGAP1 (mouse). The signal from each de­
tected pair of PLA probes was visualized as an individual 
fluorescent dot (Fig. S4 B). IQGAP1–MP1 PLA was positive in 
p14f/;myc6­MP1 MEF cells, but not in p14f/ MEFs, which we 
used as control cell line. This result supports our previous re­
sults and suggests that the interaction of MP1 and IQGAP1 oc­
curs on late endosomes.
Absence of p14–MP1 or blockage of 
Arl8b-dependent late endosomal transport 
causes IQGAP1 accumulation in FAs
Next, we examined the subcellular localization of IQGAP1. 
Immunofluorescence experiments of cells migrating into a wound 
revealed that IQGAP1 displayed mainly cytoplasmic localization 
and was enriched at the leading edge of control cells (p14f/ MEFs; 
Fig. 7 A, white arrows) as previously described (Watanabe 
et al., 2004), but a small portion of IQGAP1 was also found in 
FAs (Fig. 7 A, red arrows). In contrast, IQGAP1 was reduced at 
the rim of the leading edge and strongly accumulated in FAs of 
p14/ MEFs, where it colocalized with Paxillin (Fig. 7 A, red 
arrows). To further investigate the distribution of IQGAP1 in de­
tail, we performed a cell­spreading assay and compared IQGAP1 
localization at different time points after cell plating (Fig.7 B). 
At 30 min and 1 h after plating, control and p14­depleted cells 
looked indistinguishable in terms of morphology and IQGAP1 
localization. At 2 h after plating, control as well as p14 knock­
out MEFs developed Paxillin­positive FAs, which in both cases 
showed a colocalization with IQGAP1 (red arrows). However, 
as described above, in p14f/ MEFs a major IQGAP1 fraction 
was enriched at the plasma membrane (white arrows), whereas 
in the p14/ MEFs an accumulation on elongated FAs was ob­
served (red arrows).
Moreover, interruption of late endosomal traffic by the 
Arl8b RNAi depletion caused relocalization of IQGAP1 protein 
in control p14f/ MEFs similar to that observed in p14/ MEF: 
Figure 7. Absence of p14–MP1 or blockage of Arl8b-dependent late endosomal transport causes IQGAP1 accumulation in FAs. (A) IF: anti-Paxillin and 
anti-IQGAP1 antibodies. IQGAP1 localizes to the leading edge in p14f/ (white arrows) and colocalizes with Paxillin in FAs in p14/ MEFs (red arrows). 
(B) IF: anti-Paxillin and anti-IQGAP1 antibodies. Shown are different time points during spreading of p14f/ and p14/ MEFs. White arrows indicate ac-
cumulation of IQGAP1 at the leading edge in control MEFs. Red arrows point at IQGAP1 localization at Paxillin-positive FAs in control and p14/ MEFs. 
(C) IF: anti-LAMP1 (green), anti-IQGAP1 (red) antibodies, and Hoechst (blue). IQGAP1 localizes to the leading edge in p14f/ MEFs treated with control 
RNAi (white arrows) and localizes to FAs upon Arl8b depletion (red arrows). (D) p14f/ MEFs treated as in C. IF: anti-Paxillin and anti-IQGAP1 antibodies. 
Note IQGAP1 localization to the leading edge in p14f/ MEFs treated with control RNAi (white arrows) versus colocalization of IQGAP1 and Paxillin in 
FAs upon ARl8b depletion (red arrows).
resulted in reduced cell migration and significant FA elongation 
in control cells.
Moreover, our data demonstrated that the absence of 
p14–MP1 from late endosomes caused significant FA elongation, 
decrease of FA turnover, and affected the ability of cells to mi­
grate. Our FRAP experiments revealed that Paxillin molecules 
were not efficiently exchanged in p14/ MEFs. We also ob­
served that FAs in p14­depleted cells were more stable and ex­
isted longer than in control cells. Thus, elongated FAs were less 
dynamic and consequently led to a cell migration defect. How­
ever, not late endosomal transport per se, but the presence of the 
p14–MP1 complex on the late endosomes seemed to be impor­
tant for the FA remodeling because neither restoration of p14–
MP1 at the plasma membrane nor cytoplasmic complexes could 
rescue impaired FAs in p14/­deficient cells, and p14–MP1­
depleted Rab7 endosomes still targeted FAs.
The p14–MP1 complex was previously described to scaf­
fold MAPK signaling. MAPK plays an important role in FA 
Formation and disassociation of FAs is precisely controlled 
by diverse signaling pathways as well as by modulation of tensile 
forces (Broussard et al., 2008). Recent publications showed new 
and unexpected roles for endosomes in regulating cell migration 
(Sadowski et al., 2009; Scita and Di Fiore, 2010; Schiefermeier 
et al., 2011). Interestingly, previous findings demonstrated a spe­
cific regulation of FA disassembly by MT targeting (Kaverina 
et al., 1999). Blockage of the kinesin motor activity, either via 
microinjection of antibodies or of a kinesin­1 heavy chain con­
struct mutated in the motor domain, induced a dramatic increase 
in the size and reduction in number of FAs, mimicking the effect 
observed after MT disruption by nocodazole (Krylyshkina et al., 
2002). This would suggest the involvement of the kinesin­dependent 
transport of certain proteins/organelles to FAs, necessary for the 
release of adhesion components. Our data confirm and extend 
these observations because depletion of Arl8b protein that assures 
kinesin­1 binding to the late endosomal membrane (Bagshaw et al., 
2006; Hofmann and Munro, 2006; Rosa­Ferreira and Munro, 2011) 
Figure 8. In the absence of p14–MP1 endosomal signaling, down-regulation of IQGAP1 by RNAi rescues FAs and cell migration. (A) IF: anti-Paxillin and 
anti-IQGAP1 antibodies. (B) Left: quantification of average FA length in MEFs transfected with control or IQGAP1 RNAi. Mean in percent ± SEM is com-
pared with control p14f/ MEFs transfected with control RNAi (taken as 100%). Right: calculation of speed of migration in wound-healing assays. Mean 
in µm/h ± SEM. Importantly, only cells that had strong down-regulation of IQGAP1 (no signal on IF using anti-IQGAP1 antibodies as in A) were used for 
the calculation. See also Table S1.
Waterman­Storer, 2006). Also, a balance between adhesion 
strength and myosin activity is required for optimal migration 
(Gupton and Waterman­Storer, 2006).
Our data show that most of the FA targeting by p14–MP1 
takes place in mature sliding FAs, where the balance of myosin­
dependent contractile forces plays an important role (Vicente­
Manzanares et al., 2007). It is tempting to speculate that p14–MP1 
interaction with IQGAP1 plays a role in regulation of contrac­
tility. Furthermore, both MP1 and IQGAP1 were shown to in­
teract with PAK1 (Noritake et al., 2005; Pullikuth et al., 2005). 
PAK1 plays a complex role in regulation of cell migration; in­
teraction partners of PAK1 include Rac, MAPK, and myosins 
(Manser et al., 1994; Frost et al., 1998; Sanders et al., 1999; 
Delorme­Walker et al., 2011). Future studies should evaluate 
the exact relations between MP1, IQGAP1, PAK1, and myosin at 
local FA levels.
Based on our data we propose the following model. In mi­
grating cells, IQGAP1 is localized to the plasma membrane and 
to FCs. Upon maturation of FCs into FAs and further dynamic 
FA turnover, FAs are targeted by p14–MP1 late endosomes. 
Consequently, IQGAP1 is removed from FAs and recycles back 
to the plasma membrane. This removal of IQGAP1 no longer 
occurs in the absence of p14 and IQGAP1 begins to accumulate 
at FAs. It is likely that interaction partners of IQGAP1 will also 
begin to accumulate and thereby contribute to the loss of FA 
dynamics. Thus, loss of p14 results in a phenotype where new 
FCs are not efficiently formed, mature FAs are elongated and 
less dynamic, and cell migration is impaired. These results led 
us to conclude that the removal of IQGAP1 excess could be es­
sential for the regulation of FA dynamics during cell migration 
and requires local p14–MP1 late endosomal targeting of FAs.
Materials and methods
Tissue culture, transfections, and RNAi
HeLa, NIH3T3, and MEF cells were grown in high glucose DMEM supple-
mented with 10 mM Hepes, pH 7.3, 100 IU/ml penicillin, 100 µg/ml 
streptomycin, and 10% FC at 37°C, in 5% CO2 and 95% humidity. Media 
and reagents for tissue culture were purchased from Gibco. Cells were 
transfected with Lipofectamine 2000 (Invitrogen) following the manufactur-
er’s instructions. RNA interference of IQGAP1 and Arl8b were performed 
using Thermo Fisher Scientific’s SMARTpool siRNAs against the corre-
sponding targets and Saint-Red (Synvolux Therapeutics) as a transfection 
reagent. As a control, siCONTROL Nontargeting siRNA Pool was used 
(Thermo Fisher Scientific).
Antibodies and reagents
The monoclonal mouse anti–-tubulin antibody, DAPI, and Hoechst (Bis-
benzimide H33258) were obtained from Sigma-Aldrich. The rabbit anti-
Arl8b polyclonal antibody was bought from ProteinTech. The rabbit 
polyclonal antibody against IQGAP1 was obtained from Santa Cruz Bio-
technology, Inc., and the mouse monoclonal anti-IQGAP1 was purchased 
from BD. The mouse monoclonal anti-Paxillin antibody was bought from 
EMD Millipore, and the rat anti-LAMP1 (CD107a) antibody was purchased 
from Merck. The rabbit polyclonal anti-p18 antibody was obtained from 
Atlas Antibodies. For the rabbit polyclonal anti-p14 antibody the serum 
was raised against the GST fusion protein of p14 and for the rabbit poly-
clonal anti-MP1 antibody the serum was raised against the peptide Kp532 
(CVSDRDGVPVIKVANDSAPEHALR) as described previously (Teis et al., 
2002). For the HeLa coimmunoprecipitation the rabbit monoclonal MP1 
antibody from Epitomics was used. Rabbit polyclonal anti-Myc antibody 
was from Gramsch Laboratories. The rabbit polyclonal anti-Zyxin antibody 
was obtained from ProteinTech. The Alexa Fluor 568 phalloidin–, Alexa 
Fluor 488–, and Alexa Fluor 568–conjugated anti–mouse and anti–rabbit 
formation as well as disassembly (Chen et al., 1994; Katz et al., 
2007; Pullikuth and Catling, 2007). It was shown that treatment 
of different cell types with MEK­to­ERK inhibitors results in the 
formation of enlarged FAs and impaired migration of cells in re­
sponse to various stimuli (Klemke et al., 1997; Webb et al., 2004), 
whereas MAPK­dependent phosphorylation of FA components 
was suggested to cause these defects (Brown et al., 1998; Parsons 
et al., 2000; Webb et al., 2005). However, in the MEF cells inves­
tigated here (p14/ vs. control p14f/ MEFs), we did not identify 
differences in the phosphorylation of Paxillin (Ser126/Tyr118), 
FAK (Tyr925/576/577), Cofilin (Ser3), and IQGAP1 (unpub­
lished data). The phospho­regulation of FA protein(s) in the ab­
sence of the p14–MP1 complex will in the future require large 
and comprehensive phosphoproteomics analyses.
How does the late endosomal traffic of p14–MP1 com­
plexes regulate FAs? In our present work we have identified 
IQGAP1 as a novel interaction partner of MP1. We observed 
IQGAP1 accumulation in FAs upon loss of p14, which was also 
phenocopied by Arl8b RNAi depletion. Interestingly, IQGAP1 
accumulated both in FAs of control and p14­depleted cells dur­
ing FA maturation. Our data suggest that IQGAP1 accumulation 
may be the cause of impaired FA dynamics because down­regu­
lation of IQGAP1 by RNAi could rescue FAs and the migration 
defect initially observed in p14/ MEFs.
IQGAP1 was proposed to regulate the actin cytoskeleton, 
microtubules, and cell migration by multiple pathways including 
small GTPases and MAPK signaling (Hart et al., 1996; Roy et al., 
2004; Brown and Sacks, 2006). Although IQGAP1 knockdown 
caused slight elongation of FAs and formation of protrusions in 
control p14f/ cells (unpublished data), in contrast with previ­
ously published observations (Fukata et al., 2002; Mataraza et al., 
2003) no reduction in speed of cell migration was observed. 
We did not further evaluate the role of the IQGAP1 in the actin 
dynamics of MEFs because this effect of IQGAP1 seems to be 
p14–MP1 independent.
Two recent FA proteome studies identified IQGAP1 to as­
sociate with FAs (Kuo et al., 2011; Schiller et al., 2011), although 
its function remains unclear. IQGAP1 was found to bind to the 
integrin­linked kinase ILK in keratinocytes, where IQGAP1 colo­
calized with ILK in FCs, but not in FAs (Wickström et al., 2010). 
Thus, it seems that IQGAP1 functions in an ILK­dependent 
manner in young FCs and in a p14–MP1­dependent manner in 
mature FAs. Clearly the identification of downstream effectors 
of IQGAP1 function in FCs and FAs will help to explain how 
IQGAP1 functions during cell migration.
IQGAP1 was previously shown to bind myosin light chain 
2 (Weissbach et al., 1998; Wu et al., 2003). Budding and fission 
yeast IQGAP proteins were demonstrated to anchor myosin II at 
the division site (Fang et al., 2010; Laporte et al., 2011). Recently, 
IQGAP2 was found to be antagonized by IQGAP1 in modula­
tion of myosin­dependent mechanotransduction (Kee et al., 
2012). However, the functional consequences of this interaction 
in mammalian cells remain to be elucidated. In fibroblasts, ac­
tomyosin contractility plays a dual role in the process of cell 
migration. Myosin­dependent tensile forces trigger adhesion matu­
ration (Vicente­Manzanares et al., 2007), whereas reversing the 
maturation signal drives adhesion disassembly (Gupton and 
with a 0.13 NA/4× air objective (Nikon). Acquisition was controlled by live-
cell imaging analysis system software (Cell-IQ Imagen v.2.9.5.c; Chip-Man 
Technologies, Ltd.). Cells were kept at 37°C and 5% CO2 during imag-
ing. To analyze single-cell migration in the wound-healing assay and ran-
dom cell migration assay, the “Manual Tracking” plugin (ImageJ v1.48o) 
was used to track single cells. The speed parameter was calculated by ana-
lyzing the acquired data with the Chemotaxis and Migration Tool 1.01 plu-
gin (ibidi).
Detection of protein–protein interactions by PLA (Duolink) was per-
formed in situ according to the manufacturer’s suggestions (Olink Biosci-
ence). In brief, cells were cultured on coverslips, fixed for 20 min in cold 
(20°C) methanol, and blocked and incubated in a primary antibody as 
described above for cell staining, followed by a 2-h incubation in rabbit 
and goat PLA PLUS and PLA MINUS probes and a 15-min hybridization, 
15-min ligation, 90-min amplification, and 60-min detection according to 
the manufacturer’s protocol. Nuclei were counterstained with DAPI (blue). 
Rabbit anti-myc (to detect MP1) was coupled with mouse anti-IQGAP1. To 
maximize signal strength, samples were incubated in primary antibody 
overnight (4°C). All steps after primary antibody incubation were per-
formed at 37°C.
FRAP
FRAP data of mCherry-Paxillin–expressing MEFs were acquired with a con-
focal microscope (model SP5; Leica) equipped with a CO2 incubation 
chamber using a 1.2 NA/63× water objective and LAS AF acquisition 
software (Leica). mCherry fluorescence was acquired as follows: excita-
tion, 561-nm laser; emission, 575–732 nm. Several 12-µm2 FA areas 
(1.5 µm × 8 µm) were photobleached (bleach pulse with the 561-nm DPSS 
laser and the 488-nm argon laser lines) in each cell. FRAP was monitored for 
40 frames at 0.7 s/frame and additional 15 frames at 10 s/frame. FRAP 
data for the FRAP regions, a background region, and the “whole-cell region” 
(reference region) were exported from the LAS AF software and further an-
alyzed with MATLAB. In brief, FRAP data were processed according to the 
double-normalization method, correcting for both background and bleaching 
in order to enable comparisons between different cells. Double-normalized 
FRAP data were averaged and fitted to a single exponential recovery curve 
to calculate recovery half-life and immobile fraction.
Two-hybrid screen
A bait fragment was generated by insertion of mouse MP1(1–124) into 
pB29 (LexA, N-terminal fusion). As prey library, the human placenta RP4 
from Hybrigenics was used. The screen was performed using 20 mM of 
3-amino-1,2,4-triazole. Overall, 327 primary clones were processed, lead-
ing to the identification of 56 interactions. From the obtained clones, 120 
corresponded to antisense sequences that were not considered as relevant 
or included in the results. Among the interacting partners of MP1 we found, 
as expected, five clones corresponded to p14. Based on the number of hits 
and on results from previous two-hybrid screens (particularly important for 
the identification of false positives), Hybrigenics has derived a global predic-
tion score for the confidence of each interaction. A very high confidence score 
was asserted for six interacting proteins, among them human IQGAP1 (Gen-
Bank accession no. NM_003870). IQGAP1 was found in 24 of the 327 
clones processed.
Generation of stable cell lines
p14f/ and p14/ MEFs were generated as described previously (Teis et al., 
2006). In brief, the single mouse p14 gene (NCBI Gene no. 83409) is 
located on chromosome 3. Exons 1–4 of p14 were flanked by loxP sites 
to create a conditional allele in HM1-ES cells, which were injected into 
C57BL/6 blastocysts. All mice were maintained on a mixed genetic back-
ground of C57BL/6 and 129/Sv. To generate floxed p14 alleles, p14targ/targ 
mice were crossed with hACTB::Flpe mice. The p14-null allele, p14/+, 
was generated by crossing p14targ/targ with MORE mice. p14f/ MEFs were 
derived from day 13.5 embryos, E1A immortalized, and infected with an 
adenovirus-expressing Cre to yield p14/ MEFs. The p14-GFP MEFs 
were generated as described previously (Obexer et al., 2007; Stasyk et al., 
2010). In short, pEGFP-p14 was expressed in p14/ MEFs using retro-
viruses. The pEGFPp14 fusion protein was constructed by inserting p14 
in a pEGFP-C1 vector (Takara Bio Inc.) and subcloned in a pLib-MCS2-
iresPURO vector.
p14f/ and p14/ MEFs stably expressing myc6-MP1 were gen-
erated as follows. PCR products introducing BamHI and SalI sites in 
mouse Myc6-MP1wt were amplified, and upon digestion with the same 
enzymes the products were subcloned into the retroviral transfer vector 
pLIB-MCS2-iresPURO.
secondary antibodies and mouse monoclonal anti-Xpress antibody was 
purchased from Molecular Probes. Nocodazole was bought from EMD 
Millipore and applied on cells (10 µM) for 1 h. Western blotting was per-
formed as published previously (Fialka et al., 1997).
Plasmid DNA constructions
mCherry-Paxillin-C3 was generated by replacing the YFP sequence of the 
pYFP-Paxillin-C3 expression vector (vector backbone: pYFP-C3) provided 
by B. Geiger (The Weizmann Institute of Science, Rehovot, Israel; Zaidel-Bar 
et al., 2007) and introducing mCherry cDNA, provided by R.Y. Tsien (Uni-
versity of California, San Diego, La Jolla, CA; Shaner et al., 2004). The YFP 
sequence from pYFP-Paxillin-C3 was removed upon digestion with HINDIII 
and AgeI enzymes following the manufacturer’s instructions (Fermentas). 
PCR products introducing HindIII sites in mCherry fragment sequence 
were amplified and were further subcloned into pYFP-Paxillin-C3 using the 
Rapid DNA Ligation kit (Roche). For the mRuby-Paxillin construct, Paxillin 
cDNA was PCR amplified and ligated into a pENTR4-mRuby2 vector 
using EcoRV and XbaI restriction sites N terminally and in frame of the 
mRuby2 fluorescent protein and sequence verified. pENTR4-mRuby2 was 
generated by ligating mRuby2 cDNA into the multiple cloning site of a 
pENTR4 vector (Invitrogen) via NcoI and HindIII restriction sites. mRuby2-
tagged Paxillin was subsequently cloned out of the pENTR4 vector 
backbone in the retroviral expression vector pQCXIN-DEST using Gate-
way multicloning technology (Invitrogen). GFP-Rab7 (vector backbone: 
pEGFP-C1) was provided by C. Bucci (Department of Clinical and Experi-
mental Medicine, Federicoll, Napoli, Italy; Bucci et al., 2000). Cloning of 
mCherry-Rab7 PCR was performed using GFP-Rab7 as a template. Inser-
tion of HindIII and SalI sites on the ends of Rab7 cDNA allowed for the 
digestion and subsequent ligation into pmCherry-C1. MP1-GFP (vector back-
bone: pEGP-C1) and p14-CAAX were described previously (Wunderlich 
et al., 2001). In brief: CAAX-tagged p14 was constructed by placing a 
linker sequence encoding the last 21 amino acids of human K-ras at the 
C terminus of the p14 cDNA, replacing the STOP codon. Further, p14-
CAAX was cloned in frame with the His6/Xpress tag into pEF4/HisC vec-
tor (Invitrogen).
IF, time-lapse microscopy, TIRF, and PLA
IF was performed as described previously (Teis et al., 2002). In brief, cells 
were fixed with pre-warmed 4% paraformaldehyde in cytoskeleton buffer 
(10 mM Pipes, pH 6.8, 150 mM NaCl, 5 mM EGTA, 5 mM glucose, 
5 mM MgCl2, 5 mM Na4P2O7, 2 mM Na3OV4, 50 mM NaF, and 20 mM 
-glycerophosphate) for 20 min at room temperature, after washing in CB 
and 2 min permeabilization in 0.1% Triton X-100 in CB. Washed cells 
were blocked for 1 h in a blocking solution (1% BSA, 5% horse serum, and 
15% goat serum [both from Gibco] in PBS), incubated for 1 h with first 
antibody, washed in PBS, incubated for 30 min with secondary antibody, 
washed in PBS, and mounted in Mowiol (EMD Millipore). Images were 
taken at room temperature with either an inverted microscope (Axiovert 
200; Carl Zeiss) with a 0.4 NA/32× air objective or a confocal micro-
scope (AxioImager M1.2; Carl Zeiss) with a 1.4 NA/63× oil objective 
equipped with a CCD camera (CoolSNAP HQ2; Photometrics), and acqui-
sition was controlled by the AxioVision release 4.5 SP1 software (Carl 
Zeiss). For time-lapse microscopy, cells were kept in phenol red–free 
DMEM medium (Sigma-Aldrich), supplemented with 10% FC (Gibco) Time-
lapse movies were taken on the Axiovert 200 microscope equipped with a 
0.3 NA/10× and 0.4 NA/32× air objective and a 1.4 NA/63× and 1.4 
NA/100× oil objective. All figures were prepared in Photoshop, videos in 
ImageJ (National Institutes of Health) and Imaris (Bitplane). Image shown 
in Fig. 3 D was deconvolved using Imaris, as stated in the Fig. 3 legend. 
Scripts used in Imaris software are described in the Supplemental material. 
Images were taken at 37°C in a CO2 incubation chamber. 
TIRF microscopy. Images were captured using an inverted microscope 
(Axiovert 200M; Carl Zeiss) with a 1.6 NA/100× oil objective and a CCD 
camera (CoolSNAP HQ; Photometrics). Acquisition was controlled by 
MetaMorph Software (Molecular Devices). TIRF images were collected at 
room temperature. For TIRF movies concerning FA turnover, cells stably ex-
pressing mRuby-paxilin were plated in Leibovitz’s L-15 medium (Invitrogen) 
without phenol red on 35-mm Petri dishes with a glass bottom (ibidi). Im-
ages were taken with an iMIC microscope (FEI Munich GmbH) equipped 
with a 1.49 NA/60× oil objectives and a CMOS camera (Orca Flash 4.0; 
Hamamatsu Photonics) at 37°C. Acquisition was controlled by Life Acquisi-
tion software (FEI Munich GmbH). For the random single-cell migration 
assay, cell were plated with full media in a 24-well plate and covered with 
a CellSedure lid (Chip-Man Technologies, Ltd.). Time-lapse imaging was 
done using a Cell-IQ v.2 system (Chip-Man Technologies, Ltd.) equipped 
overlaying positions of individual endosomes onto the FA mask (in percent-
age of overlay of two fluorescent signals array) per frame of the video se-
quence. Temporal changes of FA positions (FA tracking) were calculated 
using Imaris and were shown using pseudocolored lines. Overall targeting 
was calculated over the whole sequence. To calculate which part of the in-
dividual FA is targeted, a method modified from di Penta et al. (2009) was 
used. FA signal was dissected in respect to the time domain. Dynamic and 
stable segments were dissected by simple arithmetical analysis along the 
time course of the adhesion signals (for example, subtracting the previous 
image frame from the current image frame identified newly added parts of 
the adhesion sites). The other parts were identified respectively. Analysis 
was completed in 10 cells from 10 independent time-lapse experiments. 
The analysis was realized using the ImageJ package and the JACoP plug-in 
(Bolte and Cordelières, 2006; http://rsb.info.nih.gov/ij/).
Coimmunoprecipitation
MEFs were lysed by sonication in 50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 
1% Triton X-100, 0.5% sodium deoxycholate, 10 mM EDTA, and protease 
inhibitor cocktail. HeLa cells were lysed in 50 mM Tris-HCl, pH 8.0, 
150 mM NaCl, 1% NP-40, 5 mM EDTA, and protease inhibitors. Subsequent 
steps were similar for both cell types. In brief, lysates containing 3 mg of 
total protein per sample were used for immunoprecipitation. After 20 min 
of preclearing with Ultralink G beads (Thermo Fisher Scientific), the super-
natant was subjected to immunoprecipitation using the respective antibody 
for 30 min on ice. Ultralink G beads were added after incubation with rota-
tion for 1 h at 4°C. Beads were washed three times in the corresponding 
lysis buffer. The immune complex was eluted by 5 min of incubation at 
95°C in sample buffer and separated by SDS-PAGE (Fialka et al., 1997).
Transferrin uptake experiments
MEFs were incubated on ice for 1 h with 50 ng/ml Alexa Fluor 594–
transferrin (Invitrogen) and allowed to uptake for 0–30 min at 37°C. Cells 
were fixed in 4% paraformaldehyde, mounted in Mowiol, and analyzed 
by microscope (AxioImager M1.2; Carl Zeiss).
Statistics
Length of FAs was measured in ImageJ. Values were transferred into SPSS 
and Excel programs and analyzed by Student’s t tests. Results are expressed 
as means ± SD and SEM in absolute numbers (µm) and percentages (%). 
SEM was calculated as follows: standard deviation was divided by the 
square root of the sample size (amount of calculated FAs in a given sample). 
F = 334,396 and P < 0.001 were considered significant for these studies.
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The inducible MP1 knockdown HeLa cells were produced as follows. 
The construct (V2THS_98045 = RHS4696-99636658) with mature sense 
5-CACAGAAATGGTTCAGTCT-3 in pTRIPZ was from Thermo Fisher Scientific.
Lentiviral supernatant was prepared by introducing the vector together 
with the Trans-Lentiviral Packaging Mix (Thermo Fisher Scientific) and Arrest-In 
transfection reagent (Thermo Fisher Scientific) into the 293LTV packaging cell 
line (LTV-100; Cell Biolabs, Inc.). Three days after transfection, the culture 
supernatant was filtered through a polyethersulfone filter (514-0075l; VWR 
International), and polybrene was added to 4 µg/ml and used to infect HeLa 
cells (Sigma-Aldrich). The cells were then selected 3 days after transduction 
with 1 µg/ml puromycin for 2 weeks.
Flow cytometry (FACS)
Flow cytometry was performed as described previously (Czuchra et al., 
2006). In brief, 500,000 MEFs were used per staining. Cells were washed 
in 1% BSA/PBS and incubated with first antibody for 10 min at room tem-
perature after a 30–40-min incubation on ice. First antibody was diluted 
either in FACS-Tris solution (24 mM Tris-HCl, pH 7.4, 137 mM NaCl, and 
2.7 mM KCl) or in FACS-Tris + 5 mM MnCl2. Washing was performed in 
1% BSA/PBS. Then cells were incubated with secondary antibody for 
15 min on ice and washed in 1% BSA/PBS. Propidium iodide was added 
before measurements. The following antibodies were used for the assay: anti-
1 (AbD Serotec), -5, -6, -V, -1, -2, -3, -4, and -7 integrins (all 
obtained from BD). Biotinylated (anti-3, -5, and -v integrins) antibodies 
were detected with streptavidin-Cy5 (Jackson ImmunoResearch Laborato-
ries, Inc.). The 9EG7 antibody was from BD. Anti–rat FITC and anti–hamster 
FITC were from BD. To assess autofluorescence and nonspecific staining, cells 
were stained with IgM isotype-FITC, IgG2A isotype-FITC, or streptavidin-Cy5 
(all obtained from BD).
Preparation of fusion proteins
As a control we used the pGEX-6P3 GST expression vector from GE Health-
care. The wild-type mouse MP1 sequence flanked by BamHI and EcoRI 
sites was amplified by PCR. The obtained product was then subcloned into 
pCR-blunt using the Topo-kit. The intermediate construct was digested with 
BamHI and EcoRI and the obtained insert ligated into the corresponding 
sites of pGEX4T1 (GE Healthcare). Wild-type human IQGAP1 cDNA was 
subcloned into the pGEX-2T vector. This construct was provided by D. Sacks 
(Department of Laboratory Medicine, National Institutes of Health, 
Bethesda, MD; Li and Sacks, 2003). GST fusion proteins were expressed 
in Escherichia coli and isolated with glutathione-Sepharose as described 
previously (Ho et al., 1999). In brief, GST and GST-MP1 were induced 
with 1 mM IPTG for 3 h at 37°C. GST-IQGAP1 was induced with 0.1 mM 
IPTG for 2 h at 16°C. Bacterial cultures were lysed by sonication in 50 mM 
Tris-HCl, pH 8.0, 2 mM DTT, 150 mM NaCl, 1 mg/ml lysosime, 10 µg/ml 
DNaseI, and protease inhibitors.
Pull-down experiments
The obtained E. coli lysates expressing GST, GSTMP1, or GSTIQGAP1 
were bound to glutathione-Sepharose beads at 4°C. The beads were then 
washed with GST lysis buffer in preparation for the pull-down experiment. 
In parallel, HeLa cells were lysed in 50 mM Tris-HCl, pH 7.5, 250 mM 
NaCl, 1% NP-40, 50 mM NaF, 1 mM Na3VO4, 0.5 mM PMSF, and prote-
ase inhibitors and precleared with glutathione-Sepharose beads. The pre-
cleared HeLa lysates were incubated with immobilized GST, GST-IQGAP1, 
or GST-MP1 on a rotator at 4°C for at least 3 h. After washing in 50 mM 
Tris-HCl, pH 7.5, 250 mM NaCl, 1% NP-40, and 50 mM NaF, beads 
were resuspended in sample buffer and boiled.
Calculation of focal adhesion targeting
Image analysis was performed with ImageJ and Imaris software using custom-
designed scripts (for details see Supplemental material). First, Paxillin-
positive FAs and MP1-positive endosomes were thresholded and masked 
using ImageJ. Next, individual endosomes and FAs were identified on the 
basis of their fluorescence intensities using a local maxima thresholding 
approach essentially as described previously (Teis et al., 2006) and their 
geometric center was used for further analysis. In short, images have been 
preprocessed with an unsharp mask filter (sigma of 3 pixels and weight of 
0.8 pixels) in order to define the borders of the organelles more clearly 
and suppress background noise. Images were consequently manually 
thresholded based on intensity levels. Image histograms were used as indi-
cation for separation of background and signal and transferred to binary 
masks. The image sequences were next transferred to Imaris for further 
processing, tracking, and determination of their geometric centers (see 
Supplemental material). FA targeting was evaluated by quantification of 
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